Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 284

1.

Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: A nested case-control study.

Ofori B, Oraichi D, Blais L, Rey E, Bérard A.

Birth Defects Res B Dev Reprod Toxicol. 2006 Aug;77(4):268-79.

PMID:
16929547
2.

First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.

Bérard A, Ramos E, Rey E, Blais L, St-André M, Oraichi D.

Birth Defects Res B Dev Reprod Toxicol. 2007 Feb;80(1):18-27.

PMID:
17187388
4.

Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.

Cook JC, Jacobson CF, Gao F, Tassinari MS, Hurtt ME, DeSesso JM.

Birth Defects Res B Dev Reprod Toxicol. 2003 Feb;68(1):5-26. Review.

PMID:
12852480
5.

Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.

Moride Y, Ducruet T, Boivin JF, Lavoie F, Rochon S.

Can J Clin Pharmacol. 2005 Summer;12(2):e201-11. Epub 2005 Jun 17.

PMID:
15998959
6.

Maternal use of acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), and muscular ventricular septal defects.

Cleves MA, Savell VH Jr, Raj S, Zhao W, Correa A, Werler MM, Hobbs CA; National Birth Defects Prevention Study.

Birth Defects Res A Clin Mol Teratol. 2004 Mar;70(3):107-13.

PMID:
15039924
7.

Duration of antidepressant use during pregnancy and risk of major congenital malformations.

Ramos E, St-André M, Rey E, Oraichi D, Bérard A.

Br J Psychiatry. 2008 May;192(5):344-50. doi: 10.1192/bjp.bp.107.042523.

8.

Risk of congenital anomalies in pregnant users of statin drugs.

Ofori B, Rey E, Bérard A.

Br J Clin Pharmacol. 2007 Oct;64(4):496-509. Epub 2007 May 15.

9.

[In utero exposure to benzodiazepine. Is there a risk for anal atresia with lorazepam?].

Bonnot O, Vollset SE, Godet PF, d'Amato T, Dalery J, Robert E.

Encephale. 2003 Nov-Dec;29(6):553-9. Review. French.

PMID:
15029090
10.

Nonsteroidal anti-inflammatory drugs in early pregnancy.

Ericson A, Källén BA.

Reprod Toxicol. 2001 Jul-Aug;15(4):371-5.

PMID:
11489592
12.

Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors.

Bar-Oz B, Einarson T, Einarson A, Boskovic R, O'Brien L, Malm H, Bérard A, Koren G.

Clin Ther. 2007 May;29(5):918-26. Review.

PMID:
17697910
13.

[Incidence of congenital defects in the children of mothers who used medications in the first trimester of pregnancy in the Czech Republic 1996-2001].

Sípek A, Gregor V, Velebil P, Horácek J, Masátová D, Svĕtnicová K.

Ceska Gynekol. 2003 Nov;68(6):401-19. Czech.

PMID:
15042851
14.

Prenatal zidovudine use and congenital anomalies in a medicaid population.

Newschaffer CJ, Cocroft J, Anderson CE, Hauck WW, Turner BJ.

J Acquir Immune Defic Syndr. 2000 Jul 1;24(3):249-56.

PMID:
10969349
15.

A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.

Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.

Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. Review.

16.

Maternal severe migraine and risk of congenital limb deficiencies.

Bánhidy F, Acs N, Horváth-Puhó E, Czeizel AE.

Birth Defects Res A Clin Mol Teratol. 2006 Aug;76(8):592-601.

PMID:
16955495
17.

Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.

Nørgaard M, Pedersen L, Gislum M, Erichsen R, Søgaard KK, Schønheyder HC, Sørensen HT.

J Antimicrob Chemother. 2008 Jul;62(1):172-6. doi: 10.1093/jac/dkn157. Epub 2008 Apr 9.

18.

Exposure to non-steroidal anti-inflammatory drugs during pregnancy and the risk of selected birth defects: a prospective cohort study.

van Gelder MM, Roeleveld N, Nordeng H.

PLoS One. 2011;6(7):e22174. doi: 10.1371/journal.pone.0022174. Epub 2011 Jul 18.

19.

Maternal febrile illnesses, medication use, and the risk of congenital renal anomalies.

Abe K, Honein MA, Moore CA.

Birth Defects Res A Clin Mol Teratol. 2003 Nov;67(11):911-8.

PMID:
14745928
20.

Maternal asthma, asthma medication use, and the risk of congenital heart defects.

Lin S, Herdt-Losavio M, Gensburg L, Marshall E, Druschel C.

Birth Defects Res A Clin Mol Teratol. 2009 Feb;85(2):161-8. doi: 10.1002/bdra.20523.

PMID:
19067406
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk